family-supported care
BehavioralFamily video calling in the operating room
Other names: Family video calling in the operating room
NCT Number: NCT07203989
This study aims to investigate the effect of video calls with family members during the preoperative waiting period in the operating room on stress, anxiety, and surgical fear in patients undergoing transurethral resection of bladder tumor (TURBT). Bladder cancer is a common urological malignancy, and psychological problems are frequently observed in the preoperative period. The absence of family support in the operating room may increase anxiety and fear, triggering physiological stress responses and raising the risk of complications.
This multicenter randomized controlled trial will be conducted between September 2025 and March 2027 at Bitlis State Hospital and Tatvan State Hospital. The study sample will include 128 eligible patients, randomly assigned to intervention and control groups. Patients in the intervention group will have a video call with a designated family member in the operating room, while control group patients will receive routine care.
Data will be collected using the Descriptive Information Form, the Surgical Fear Questionnaire, and the Visual Analogue Scale; stress levels will be assessed through serum cortisol and glucose values. Measurements will be taken at three time points: preoperatively (T0), immediately before anesthesia (T1), and on the first postoperative day (T2).
The study is expected to demonstrate that maintaining family support through video calls in the preoperative period reduces anxiety, fear, and stress, thereby improving surgical outcomes and contributing to the development of family-centered care practices.
Trial opening soon.
Get Notified18 year–100 year
All sexes
Interventional
Not applicable
Tatvan State Hospital, Bitlis, Turkey, Bitlis, Tatvan, Turkey (Türkiye)
This study investigates the effect of family-supported video calls on patients with bladder tumor scheduled for transurethral resection (TURBT) during the preoperative waiting period in the operating room. Preoperative anxiety, surgical fear, and stress are common among surgical patients and may negatively influence physiological responses and postoperative outcomes. Allowing real-time communication with a family member through a secure digital platform may provide psychological support, reduce anxiety and fear, and mitigate stress-related physiological changes.
The study is designed as a multicenter randomized controlled trial conducted at Bitlis State Hospital and Tatvan State Hospital between September 2025 and March 2027. Eligible patients will be randomly assigned to either the intervention group, who will have a structured video call with a designated family member before anesthesia induction, or the control group, who will receive standard preoperative care without family contact in the operating room. Outcomes will include anxiety, surgical fear, and stress levels, measured using validated scales and physiological parameters. Findings from this study are expected to contribute to the development of family-centered care strategies aimed at improving perioperative psychological well-being and surgical outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Family video calling in the operating room
Other names: Family video calling in the operating room
Time frame: Anxiety levels will be measured at three different time points: T0: On the morning of the surgery, at 08:00 in the ward T1: In the operating room, immediately before anesthesia induction T2: The morning after the surgery, at 08:00
Anxiety levels will be assessed using the Visual Analogue Scale (VAS), scored from 0 (no anxiety) to 10 (worst possible anxiety). Higher scores indicate greater anxiety.
Time frame: Blood samples will be collected from patients at three different times. • T0: On the morning of surgery, in the ward at 8:00 a.m. • T1: In the operating room, just before anesthesia induction • T2: The day after surgery, at 8:00 a.m.
Serum cortisol and serum glucose levels will be measured to determine patients' stress levels. Increases in cortisol and glucose levels indicate increased stress levels.
Time frame: Patients' surgical fear levels will be measured at two different times. • T0: On the morning of surgery, in the ward at 8:00 a.m. • T1: In the operating room, just before anesthesia induction
The Surgical Fear Scale (SFS) will be used to determine the level of fear in patients.
Surgical Fear Scale: The Surgical Fear Scale was first developed by Theunissen et al. in 2014 to determine the level of surgical fear in patients undergoing surgery.
The Surgical Fear Scale consists of eight items and two subscales, scored from 0 to 10. The first four items measure fear of short-term surgical outcomes, and the last four items measure fear of long-term outcomes. Each subscale is aggregated, and the sum of the two subscale scores constitutes the total scale score. The total score for the scale ranges from 0 to 80. Low scores indicate low levels of surgical fear, while high scores indicate high levels of surgical fear.
Contact information is provided by the study sponsor or research team.
Aynur KOYUNCU
CONTACT
Erdoğan YAKIT
CONTACT
Bitlis Eren University
Other
The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical Fear in Patients Undergoing Transurethral Resection of Bladder Tumor: A Multicenter Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07534631
Bladder Tumor (TURBT), Female Urogenital Diseases
Banī Suwayf, Beni Suef Governorate, Egypt
View Trial DetailsNCT07464145
Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)
View Trial DetailsNCT07053722
Bladder (Urothelial, Transitional Cell) Cancer, Female Urogenital Diseases
View Trial DetailsNCT07053735
Bladder (Urothelial, Transitional Cell) Cancer, Female Urogenital Diseases
View Trial Details